Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark C. Scholz
The Risks of Taking Testosterone Treatments With Prostate Cancer
Testosterone replacement can be dangerous for men with prostate cancer if not managed carefully. It's generally safe for men who have low-risk prostate cancer and have completed treatment after an appropriate waiting period. Testosterone therapy may increase the risk of blood clots and heart problems, especially in older men. Testosterone replacement can be dangerous for people who have prostate cancer. When it is used, it has to be used with caution.
How PSA Doubling Time Shows a Prostate Cancer Relapse
PSA doubling time is important for finding a relapse of prostate cancer. Treatment for a cancer relapse depends on PSADT and the cancer's original risk category If you or someone you're close to has prostate cancer, you'll hear a lot about the PSA blood test and the PSA doubling time (PSADT). PSA helps medical providers screen for and diagnose prostate cancer at an early stage. But there's more to the test than just that.
Why Gleason 6 Prostate Cancer May Not Need Immediate Treatment
Gleason score 6 is the lowest grade of prostate cancer. This rating means that the prostate cancer is considered to be low- or very low-risk disease, or group 1. Most of these tumors are found during routine prostate cancer screenings. Gleason 6 prostate tumors grow slowly and may never cause a problem—or even need treatment. Still, they should be monitored. Screening for prostate cancer involves the prostate-specific antigen (PSA) test and a digital rectal exam.
CAOEC's Top Executive Offers Solutions To Counter Tariff Threat
Stay ahead - Start a free trial Unrivalled Canadian energy news, insights, and data that informs decisions and grows careers. Start your 14-day free trial Already a member? Sign in
How Receipt Capture Fills the Gaps in Consumer Buying Data for Retailers
Digital receipts are now a staple of consumer transactions, available through apps on various devices and offering businesses a valuable new data source. Gathering digital records like receipts reveals deep insights into consumer behavior and enables competitive benchmarking. Why Traditional Research Falls Short Retailers and e-tailers regularly leverage internal data to gain insights into their customers' buying patterns, but this perspective captures only a segment of overall consumer behaviors.
Invasion of the Prostate Snatchers: Revised and Updated Edition: An Essential Guide to Managing Prostate Cancer for Patients and Their Families
"A provocative and frank look at the bewildering world of prostate cancer, from the current state of the multibillion-dollar industry to the range of available treatments...Prostate cancer is a dark and mysterious country, and Mr. Blum and Dr. Scholz are good, levelheaded guides through these thickets.
Win A Copy Of The Book 'Invasion Of The Prostate Snatchers' By Mark Scholz, MD, and Ralph H. Blum
Home > Free Books > Free Giveways > Win A Copy Of The Book ‘Invasion Of The Prostate Snatchers’ By Mark Scholz, MD, and Ralph H. Blum RedCarpetCrash August 19, 20212021-08-19T02:29:55-05:002021-08-19T02:45:28-05:00 Every year almost a quarter of a million confused and frightened American men are tossed into a prostate cancer cauldron stirred by salespeople representing a multibillion-dollar industry.
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint
1. Introduction Most prostate cancer-specific deaths occur in patients with metastatic castration-resistant prostate cancer (mCRPC), frequently preceded by debilitating pain and functional compromise [1x[1]Halabi, S., Vogelzang, N.J., Kornblith, A.B. et al. Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol. 2008; 26: 2544–2549 Google ScholarSee all References][1].
The Key to Prostate Cancer, a Book Club Review with Mark Scholz
(Length of Interview: 16 min)Charles Ryan, MD interviews Mark Scholz, MD, a medical oncologist in Marina del Rey, CA about his newest book The Key to Prostate Cancer: 30 Experts Explain 15 Stages of Prostate Cancer.
Why Early Prostate Cancer Is Symptom-Free
Early prostate cancer usually has no symptoms. PSA tests are the most effective way to detect prostate cancer early. Symptoms are more likely to be caused by non-cancerous problems like infections. Google keeps track of what is searched most frequently.
JAMA Oncology | Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate CancerRelating 33 Years of Patient Clinical CareEffects of Intermittent vs Continuous Androgen Deprivation TherapyLetters
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Use of Zytiga After Lupron to Control Prostate Cancer
One of the unique characteristics of prostate cancer is its responsiveness to the withdrawal of testosterone.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark C.
Contact Mark C., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack